ILDONG HOLDINGS CO.,LTD  Logo

ILDONG HOLDINGS CO.,LTD

A holding company managing a diversified healthcare group in pharmaceuticals and bioscience.

000230 | KO

Overview

Corporate Details

ISIN(s):
KR7000230003
LEI:
Country:
South Korea
Address:
서울특별시 서초구 바우뫼로27길 2 일동제약빌딩, 서울특별시

Description

ILDONG HOLDINGS CO.,LTD. is a holding company that manages a diversified healthcare group. Its primary subsidiary, Ildong Pharmaceutical, develops, manufactures, and supplies a broad portfolio of pharmaceutical products, including over-the-counter drugs, vitamins, and antibiotics. The pharmaceutical division maintains a robust R&D pipeline focused on treating metabolic disorders, gastrointestinal diseases, and degenerative conditions. Other key subsidiaries include ILDONG BIOSCIENCE, a specialist in probiotics and functional health foods, and Ildong Healthcare, which provides healthy-lifestyle products such as water ionization units. The group collectively aims to enhance human health through its diverse offerings in pharmaceuticals, bioscience, and consumer healthcare.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-11 00:00
주식등의대량보유상황보고서(일반)
Korean 129.0 KB
2025-09-11 00:00
최대주주등소유주식변동신고서
Korean 44.3 KB
2025-08-26 00:00
주식등의대량보유상황보고서(일반)
Korean 128.8 KB
2025-08-14 00:00
반기보고서 (2025.06)
Korean 2.1 MB
2025-07-30 00:00
연결재무제표기준영업(잠정)실적(공정공시)
Korean 16.3 KB
2025-07-30 00:00
[기재정정]타법인주식및출자증권처분결정
Korean 21.5 KB
2025-07-30 00:00
타법인주식및출자증권처분결정
Korean 15.8 KB
2025-07-28 00:00
결산실적공시예고(안내공시)
Korean 4.1 KB
2025-07-08 00:00
주식등의대량보유상황보고서(일반)
Korean 136.0 KB
2025-07-08 00:00
최대주주등소유주식변동신고서
Korean 50.2 KB
2025-06-23 00:00
타법인주식및출자증권처분결정
Korean 17.1 KB
2025-05-30 00:00
기업지배구조보고서공시
Korean 1015.5 KB
2025-05-27 00:00
주식등의대량보유상황보고서(일반)
Korean 128.8 KB
2025-05-15 00:00
분기보고서 (2025.03)
Korean 1.9 MB
2025-05-12 00:00
연결재무제표기준영업(잠정)실적(공정공시)
Korean 16.3 KB

Automate Your Workflow. Get a real-time feed of all ILDONG HOLDINGS CO.,LTD filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ILDONG HOLDINGS CO.,LTD

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for ILDONG HOLDINGS CO.,LTD via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.